Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial

This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.

NCT Number	NCT07449039
Lead Sponsor	University of California, Los Angeles
Conditions	Gestational Diabetes Mellitus in Pregnancy
Enrollment	50 participants
Start Date	2025-09-28
Primary Completion	2029-12 (estimated)
Study Completion	2030-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-04